[Clinical features and prognosis of the mild cases of XXXX ].

@entity1 @entity778 @entity404 @entity66 @entity55 @entity405 @entity683 @entity6475 @entity37253 @entity221
OBJECTIVE: Analyze the clinical characteristics of the mild cases of @entity778 , as well as the relationship of clinical characteristics and @entity1 genders. METHODS: A total of 245 @entity683 (H1N1) @entity1 confirmed by viral nucleic acid detection were included in the study. The @entity1 ' personal information, signs and symptoms, lab and iconography data, disease course, negative seroconversion duration of new @entity683 (H1N1) viral nucleic acid after antiviral treatment and hospitalization stay were analyzed. Measurement data were analyzed using one-way analysis of variance (ANOVA) by software SPSS 11.5. P < 0.05 was defined as statistically significant. RESULTS: (1) Among the 245 @entity1 , 130 were males and 115 were females, yielding a sex ratio of 1.13:1. Almost 52.0% (127/245) of the @entity1 came from Australia, and 64.5% (158/245) were between 18 and 40 years old. (2) Clinical manifestations included @entity221 (98.4%, 241/245), cough (80.8%, 198/245) and throat congestion (95.9%, 235/245), and lab findings were characterized by elevated C-reaction protein (CRP, 71.0%, 174/245) and neutrophil (52.2%, 128/245). (3) Female @entity1 had significantly lower serum Prealbumin (pre-A) levels than male @entity1 [(245.04    75.3) vs (273.34    92.18) mg/L, F = 5.55, P = 0.019]. (4) The patients' serum @entity37253 levels significantly decreased after the treatment [(4.06    3.47) vs (14.54    14.68) mg/L, F = 6.18, P = 0.016], while the levels of CD3, @entity404 and @entity405 were significantly increased after treatment [(1451.23    443.97) vs (819.97    375.75) cell/  l, F = 32.61, P = 0.000; (771.33    251.92) vs (435.36    215.35) cell/  l, F = 44.43, P = 0.000; (593.16    237.19) vs (342.47    180.12) cell/  l, F = 28.518, P = 0.000, respectively]. (5) Approximately 30.6% (75/245) of the @entity1 had abnormal signs on chest CT iconography, and 22.0% (54/245) had obvious signs indicating @entity55 . The average disease course was (3.9    1.2) days, the average hospitalization stay was (5.0    1.4) days, and the negative seroconversion duration of the mRNA after antiviral treatment was (3.8    1.4) days. CONCLUSION: The @entity778 was characterized by @entity221 , cough and throat congestion, with elevated CRP and neutrophil being the most significant lab findings. The @entity6475 was able to affect multiple organs, including being able to affect hepatic synthesis of pre-A as well as immune functioning. The @entity683 was mild clinically, with @entity66 and good prognosis.
